DE69526918T2 - Arzneimittel gegen spinocerebellare degeneration - Google Patents

Arzneimittel gegen spinocerebellare degeneration

Info

Publication number
DE69526918T2
DE69526918T2 DE69526918T DE69526918T DE69526918T2 DE 69526918 T2 DE69526918 T2 DE 69526918T2 DE 69526918 T DE69526918 T DE 69526918T DE 69526918 T DE69526918 T DE 69526918T DE 69526918 T2 DE69526918 T2 DE 69526918T2
Authority
DE
Germany
Prior art keywords
represent
spinocerebellar degeneration
medicine against
ococh3
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69526918T
Other languages
English (en)
Other versions
DE69526918D1 (de
Inventor
Tetsuo Sakai
Yasunobu Antoku
Toyojiro Matsuishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69526918D1 publication Critical patent/DE69526918D1/de
Publication of DE69526918T2 publication Critical patent/DE69526918T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69526918T 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration Expired - Lifetime DE69526918T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18468294 1994-08-05
PCT/JP1995/001550 WO1996003989A1 (fr) 1994-08-05 1995-08-04 Remede contre la degenerescence spino-cerebelleuse

Publications (2)

Publication Number Publication Date
DE69526918D1 DE69526918D1 (de) 2002-07-11
DE69526918T2 true DE69526918T2 (de) 2002-12-19

Family

ID=16157531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69526918T Expired - Lifetime DE69526918T2 (de) 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration

Country Status (6)

Country Link
US (1) US5753656A (de)
EP (1) EP0722731B1 (de)
AT (1) ATE218345T1 (de)
DE (1) DE69526918T2 (de)
ES (1) ES2177654T3 (de)
WO (1) WO1996003989A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418097A1 (de) 1994-05-24 1995-11-30 Cassella Ag Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
WO1998004558A1 (fr) * 1996-07-31 1998-02-05 Artemis, Inc. Piegeurs d'oxygene actifs a base de derives de pterine
WO1998008516A1 (fr) † 1996-08-30 1998-03-05 Suntory Limited Preparations servant a la prevention et au traitement de maladies provoquees par une hypofonction de l'oxyde nitrique synthase
JP4306825B2 (ja) 1998-02-27 2009-08-05 アスビオファーマ株式会社 インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US7610233B1 (en) 1999-12-22 2009-10-27 Accenture, Llp System, method and article of manufacture for initiation of bidding in a virtual trade financial environment
US7167844B1 (en) 1999-12-22 2007-01-23 Accenture Llp Electronic menu document creator in a virtual financial environment
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
MXPA04009123A (es) * 2002-03-21 2005-09-08 C Hinz Martin Tecnologia de optimizacion del segmento del sistema de serotonina y catecolamina.
US20060110325A1 (en) * 2003-02-21 2006-05-25 Hinz Martin C Serotonin and catecholamine segment optimization technology
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
WO2005048926A2 (en) * 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
DK1708690T3 (en) * 2003-11-17 2016-11-07 Biomarin Pharm Inc TREATMENT OF PHENYLKETONURI WITH BH4
US20080207624A1 (en) * 2004-05-11 2008-08-28 Osamu Sugita Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
EP2436379A1 (de) * 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stabile Tablettenformulierung
EP1819340A2 (de) * 2004-12-08 2007-08-22 Biomarin Pharmaceutical Inc. Verfahren und zusammensetzungen zur behandlung von lungenhypertonie bei neugeborenen
WO2007067570A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
AU2008206486C1 (en) * 2007-01-12 2013-09-26 Biomarin Pharmaceutical Inc. Tetrahydrobiopterin prodrugs
US20100009997A1 (en) * 2007-01-12 2010-01-14 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug
EP2139485B1 (de) 2007-04-11 2012-10-17 BioMarin Pharmaceutical Inc. Verfahren zur verabreichung von tetrahydrobiopterin, assoziierten zusammensetzungen und messverfahren
BRPI0821970A2 (pt) * 2008-01-03 2015-06-23 Biomarin Pharm Inc Análogos de pterina para tratamento de condição responsiva a bh4
JP5066756B2 (ja) * 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
KR20190138696A (ko) * 2017-06-02 2019-12-13 후지필름 도야마 케미컬 가부시키가이샤 척수 소뇌 변성증 예방 또는 치료제
EP3807279A4 (de) * 2018-05-30 2022-04-06 PTC Therapeutics MP, Inc. Pharmazeutisch verträgliche salze von sepiapterin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
JPS5976086A (ja) * 1982-09-20 1984-04-28 ザ　ウエルカム　フアウンデ−シヨン　リミテツド プテリジン化合物
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
DE69229270D1 (en) * 1991-11-16 1999-07-01 Suntory Ltd Rezeptor für 6(r)-l-erythro-5,6,7,8-tetrahydrobiopterin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen

Also Published As

Publication number Publication date
ATE218345T1 (de) 2002-06-15
US5753656A (en) 1998-05-19
WO1996003989A1 (fr) 1996-02-15
EP0722731B1 (de) 2002-06-05
EP0722731A1 (de) 1996-07-24
ES2177654T3 (es) 2002-12-16
EP0722731A4 (de) 1998-03-04
DE69526918D1 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
DE69526918T2 (de) Arzneimittel gegen spinocerebellare degeneration
EP1036794A4 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
WO2001072728A3 (en) Novel piperazine derivatives
AU7278500A (en) Fungicides
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
PT928788E (pt) Compostos farmaceuticamente activos
ES2072223B1 (es) Liposomas encapsulando doxorubicina.
CA2336412A1 (en) Medicament for treatment of diabetes
IL166513A0 (en) Lamellarin derivatives and pharmaceutical compositions containing the same
WO2001021608A3 (en) Novel flavonoids
EP1182193A4 (de) Medikamente gegen neuropathische schmerzen
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
AU6735894A (en) Use of phenalkylamines
EP0754683A4 (de) Etherverbindungen, ihre verwendung und zwischenprodukte zu ihrer herstellung
WO2000046210A3 (en) New process for preparing pesticidal intermediates
DE602004007181D1 (de) 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s-triazin, dieser enthaltenden Sonnenschutzzusammensetzungen und dessen Verwendungen
DE69722610D1 (de) Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
EP1026162A4 (de) Antirheumatika
DE69925225D1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
MX9206930A (es) Nuevos compuestos
AU4732096A (en) Remedy for pulmonary heart
EP0816366A4 (de) Imidazothiazolverbindungen
EP0358091A3 (de) 2-Zyklohexylpropanal-Derivate und diese enthaltende Parfümeriezusammenstellungen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP